Innocan Pharma Secures $1M in Funding Following Patent Win in India, Unlocking a Massive Market Opportunity
In a major step forward for cannabis innovation, Innocan Pharma (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has successfully closed a $1 million funding round from its largest shareholder, Tamar Innovest Ltd. This financing milestone comes just weeks after Innocan secured its first-ever patent in India for its proprietary liposomal CBD injection technology. With India’s pharmaceutical […]
